MMRGlobal Names Health IT Insurance Executive Joseph Gonzalez and
Leading Australian Physician and eHealth Innovator Dr. Joseph Grace
to Advisory Boards
LOS ANGELES, CA--(Marketwired - May 7, 2014) - MMRGlobal, Inc.
(OTCQB: MMRF) ("MMR"), a leading provider of patented Personal
Health Records (PHRs), MyEsafeDepositBox storage solutions, and
MMRPro document management and imaging systems for healthcare
professionals, today announced the appointments of Joseph Gonzalez
to the MMR Board of Advisors and Dr. Joseph Gracé to the Company's
Medical Board of Advisors. Mr. Gonzalez co-founded Secure EDI
Health Group and has served as the primary consultant for
initiatives with the nation's leading companies in the financial,
healthcare, and clinical data verticals for over 15 years. He will
assist the Company in forming strategic relationships with major
Health Information Technology solution providers. Dr. Gracé will
assist MMR with the Company's ongoing licensing and sales
initiatives in Australia in advance of scheduled meetings with MMR
executives and strategic partners later this summer.
Mr. Gonzalez has held leadership roles with industry driving
organizations and associations. He currently holds the position of
President for The Cooperative Exchange,
www.cooperativeexchange.org, the recognized resource and
representative association of the Healthcare IT Vendor and
Clearinghouse industry. Previously, he served as Vice Chairman and
Trustee of the Board of Directors to the National Dental EDI
Council, and has chaired or co-chaired committees and workgroups
within ASC X12, Workgroup for Electronic Data Interchange (WEDI),
Center for Affordable Quality Healthcare's (CAQH) CORE initiative
and the Electronic Healthcare Network Accreditation Commission
(EHNAC). He has also been a featured speaker on 4010/5010
transaction transition, Innovations in Electronic Remittance,
ICD-10 preparedness, and authored white papers on Clinical Data
& Electronic Medical Record strategies and solutions.
Dr. Gracé is a respected medical practitioner in Sydney,
Australia for more than 26 years. He is currently the Medical
Director of the North Shore Medical Group, offering specialist
medical services to patients from over 800 referring doctors.
Clinics under his purview include North Shore Heart Clinic®, North
Shore Vein Clinic® and North Shore Homecare Services.
Dr. Gracé's extensive medical experience has accorded him
Fellowships with the Australasian College of Phlebology, the Royal
Australasian College of General Practitioners, and the Australian
College of Nutritional and Environmental Medicine. In parallel with
his clinical practice, he founded the startup health IT company,
Claydata, collaborating with major research institutes to create
better e-health and EMR solutions. Amongst other achievements, Dr.
Gracé has taken Claydata's innovative eHealth technologies to the
NSW Trade & Investment's INNOVATE NSW Collaborative Solutions
conference and developed a consortium partnership with the
University of New South Wales' Asia-Pacific Ubiquitous Health Care
Research Centre. Dr. Gracé will assist MMR in introducing both the
MMR platform of patented Personal Health Record products and
services and related intellectual property along with strategic
partner 4medica's integrated EHR (iEHR®) platform to physicians,
providers, information providers and government agencies in
Australia.
Robert H. Lorsch, MMRGlobal Chairman and Chief Executive
Officer, said, "I am pleased to announce the addition of these two
exceptional individuals to our advisory boards. Mr. Gonzalez's
knowledge in health IT payer/provider solutions and services will
be extremely valuable to MMR, while Dr. Gracé is both a gifted
clinician and innovator in health IT. He is actively developing
eHealth solutions in Australia and will be invaluable in
demonstrating physician support to the use of Personal Health
Records. He is also working with us on expanding MMR's licensing
opportunities in Australia. He is as committed, as is MMR globally,
to a mission of helping Australians benefit from effective eHealth
technologies."
Members of the Company's Board of Advisors also include Dr. Buzz
Aldrin, Apollo 11 Astronaut and author; Titus Day, Managing
Director, 6 Degrees Group; Hon. Richard A. Gephardt, 22nd Majority
Leader of the U.S. House of Representatives and currently President
and CEO, Gephardt Government Affairs; C. Rowland Hanson, Strategic
Marketing Consultant, former executive with Microsoft and
Neutrogena; Hon. Asa Hutchinson, former U.S. Congressman, First
Under Secretary of Homeland Security and currently CEO and Founding
Partner, Hutchinson Group, LLC; "Sugar" Ray Leonard, Professional
Athlete and Entrepreneur; Fred Middleton, Managing Director,
Sanderling Ventures; Dr. James L. Spigarelli, former CEO and
President, Midwest Research Institute; and JJ Virgin, CNS, CHFI,
Health Correspondent, Author and Nutritionist.
The Company's Medical Advisory Board also includes Michel
Babajanian, M.D., FAC., Board-Certified Otolaryngologist and Head
and Neck Surgeon; Glenn D. Braunstein, M.D., Vice President,
Clinical Innovation and Director of the Thyroid Cancer Center at
Cedars-Sinai Medical Center; David E. Bresler, PhD, LAc, Author,
Consultant and President, Academy for Guided Imagery; Shekhar
Challa, M.D., Board-Certified Gastroenterologist and Co-Founder and
President, Kansas Medical Clinic; Jeremy Fine, M.D.,
Board-Certified in Internal Medicine; Theodore B. Goldstein, M.D.,
Board-Certified Orthopedic Surgeon and Co-Medical Director,
Cedars-Sinai Spine Center; William H. Goodman, M.D., Pulmonary and
Critical Care Physician, Academic Appointment at Dartmouth Medical
School; Cara Natterson, M.D., Board-Certified Pediatrician, Author
and Founder, Worry Proof Consulting; Lawrence D. Piro, M.D.,
Clinician, International Expert in Hematologic Malignancies, The
Angeles Clinic and Research Institute; David Charles Rish, M.D.,
Board-Certified Dermatologist; and Prediman K. (PK) Shah, M.D.,
Shapell and Webb Chair in Clinical Cardiology, Professor of
Medicine and Cardiology, and Director, Oppenheimer Atherosclerosis
Research Center at Cedars-Sinai Medical Center.
About MMRGlobal MMRGlobal, Inc., through its wholly-owned
operating subsidiary, MyMedicalRecords, Inc., provides secure and
easy-to-use online Personal Health Records ("PHRs") and electronic
safe deposit box storage solutions, serving consumers, healthcare
professionals, employers, insurance companies, financial
institutions, retail pharmacies, and professional organizations and
affinity groups. The MyMedicalRecords PHR enables individuals and
families to access their medical records and other important
documents, such as birth certificates, passports, insurance
policies and wills, anytime from anywhere using the Internet.
MyMedicalRecords is built on proprietary, patented technologies to
allow documents, images and voicemail messages to be transmitted
and stored in the system using a variety of methods, including fax,
phone, or file upload without relying on any specific electronic
medical record platform to populate a user's account. The Company's
professional offering, MMRPro, is designed to give physicians'
offices an easy and cost-effective solution to digitizing
paper-based medical records and sharing them with patients through
an integrated patient portal. Through its merger with Favrille,
Inc. in January 2009, the Company acquired intellectual property
biotech assets that include anti-CD20 antibodies and data and
samples from its FavId™/Specifid™ vaccine clinical trials for the
treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about
MMRGlobal, Inc. visit www.mmrglobal.com. View demos and video
tutorials of the Company's products and services at
www.mmrtheater.com.
Forward-Looking Statements All statements in this press
release that are not strictly historical in nature, including,
without limitation, the Company's future performance, management's
expectations, beliefs, intentions, estimates or projections,
constitute "forward-looking statements." Such forward-looking
statements involve known and unknown risks, uncertainties and other
factors that may cause the Company's actual results to be
materially different from historical results or from any results
expressed or implied by such forward-looking statements. Some can
be identified by the use of words (and their derivations) such as
"need," "possibility," "potential," "intend," "offer,"
"development," "if," "negotiate," "when," "begun," "believe,"
"achieve," "will," "estimate," "expect," "maintain," "plan," and
"continue," or the negative of these words. Actual outcomes and
results of operations and the timing of selected events may differ
materially from the results predicted, and any reported results
should not be considered as an indication of future performance.
Such statements are necessarily based on assumptions and estimates
and are subject to various risks and uncertainties, including those
relating to the possible invalidity of the underlying assumptions
and estimates and possible changes or developments in economic,
business, industry, market, legal and regulatory circumstances and
conditions and actions taken or omitted to be taken by third
parties, including customers, suppliers, business partners, agents,
potential licensees, competitors and legislative, judicial and
other governmental authorities and officials. Factors that could
cause or contribute to such differences include, but are not
limited to: unexpected outcomes with respect to intellectual
property enforcement actions, claims of intellectual property
infringement and general intellectual property litigation; our
ability to maintain, develop, monetize and protect our patent
portfolio for both the Company's health IT and biotechnology
intellectual property assets in the U.S. and internationally; the
timing of milestone payments in connection with licensing our
intellectual property; our ability to establish and maintain
strategic relationships; changes in our relationships with our
licensees; the risk the Company's products are not adopted or
viewed favorably by the healthcare community and consumer retail
market; business prospects, results of operations or financial
condition; risks related to the current uncertainty and instability
in financial and lending markets, including global economic
uncertainties; the timing and volume of sales and installations;
the length of sales cycles and the installation process; the
market's acceptance of new product and service introductions;
programs and initiatives, including the MMR Stimulus Program;
competitive product offerings and promotions; changes in government
laws and regulations and future changes in tax legislation and
initiatives in the healthcare industry both in the U.S. and
internationally; undetected errors in our products; the possibility
of interruption at our data centers; risks related to third party
vendors; risks related to obtaining and integrating third-party
licensed technology; risks related to a security breach by third
parties; risks associated with recruitment and retention of key
personnel; other litigation matters; uncertainties associated with
doing business internationally across borders and territories; and
additional risks discussed in the Company's filings with the
Securities and Exchange Commission. The Company is providing this
information as of the date of this release and, except as required
by applicable law, does not undertake any obligation to update any
forward-looking statements contained in this release as a result of
new information, future events or otherwise.
CONTACT: Michael Selsman Public Communications Co.
ms@publiccommunications.biz (310)
922-7033